Synopsis of recent research by authors named "James P Zidar"
- James P. Zidar's recent research primarily focuses on the safety and efficacy of novel drug-eluting stents (DES), particularly the biodegradable polymer Supreme DES, in various clinical scenarios including acute and chronic coronary syndromes, diabetes mellitus, and complex coronary lesions.
- Findings from the PIONEER III trial and its substudies suggest that the Supreme DES demonstrates comparable safety and effectiveness to traditional DES while potentially offering enhanced benefits in patient populations with specific conditions, such as diabetes and complex lesions.
- Additionally, Zidar's work includes investigations into the effects of renal denervation (RDN), specifically the use of alcohol-mediated RDN, which shows promise in managing blood pressure in patients on antihypertensive medications, indicating a broader interest in innovative cardiovascular treatment strategies.
